"We can't cut ourselves off and we don't now want China to cut us off, so we have to do this in a systematic way,” a US lawmaker said

China says its fully homegrown brain-computer interface was tested on a monkey, allowing it to control a robotic arm with only its thoughts

US intelligence officials say Chinese pharma companies are risking national security at a time when Washington is considering multiple bills targeting those firms access to funds

Government work report says it wants to mobilize resources to raise China's capacity for innovation to help it to become self-sufficient in emerging technologies

Shares of WuXi Biologics and its affiliate WuXi AppTec plunged again on Wednesday after US lawmakers called for a probe on whether they should face sanctions

Shares of WuXi AppTec and WuXi Biologics sank to multi-year lows on Friday because of deep concern about the proposed Biosecure Act Bill and Wuxi AppTec's ties to the Chinese military

Move to 'de-risk' supply chains is leading some biotech firms to consider using Indian drug manufacturers to produce active pharmaceutical ingredient for clinical trials or other work

US vaccine maker says it signed agreements with Shanghai officials on developing mRNA vaccines in China. Local news outlet says it is a $1-billion deal

The European Union is set to lay out strategies on 'de-risking' trade with China and other potential military rivals

AstraZeneca is looking at spinning off its business in China - listing it in Hong Kong or Shanghai - in hope that the move will protect it from rising tensions between global powers, sources have said

The US has added 43 firms – mostly Chinese – to its Entity List, banning them from receiving US exports for activities such as training army pilots and developing hypersonic missiles

China hawks in Washington blame US investors for transferring capital and valuable know-how to Chinese tech companies that could help advance Beijing's military